Mr. Pinnow, you had mentioned a very salient point in your comment to me. You said that the change in dosing and the conflicting information between regulatory agencies could lead to concern, confusion and, potentially, hesitancy.
Would you say that staying with one set of advice is the best way to prevent vaccine hesitancy in this regard, among other issues?